Webinar: Pesticides and Parkinson's
Held in partnership with the University of Edinburgh and the Journal of Parkinson’s Disease, with Edinburgh University’s Professor Tilo Kunath as chair, this next edition of our webinar series on Wednesday 3 June at 5:00 pm BST will discuss pesticides and their link to Parkinson’s....
Learn more
DAPA-PD, the phase 2 clinical trial of dapansutrile, is now underway
We are excited to announce that the first participant on the Cure Parkinson’s and Van Andel Institute co-funded trial of dapansutrile, an anti-inflammatory drug, has now received either the treatment or placebo, marking the beginning of the trial. What is DAPA-PD? Dapansutrile for Parkinson’s (DAPA-PD)…
Spring Research Update Meeting 2026: watch again
Our 2026 Spring Research Update Meeting was once again held at the renowned Royal Society of Medicine (RSM), Wimpole Street, London on Monday 20 April, where attendees listened to the latest updates from our funded research. Theme: Targeting inflammation to slow Parkinson’s progression The meeting…
International Women’s Day 2026: The importance of investigating sex and gender in Parkinson’s research
Despite growing evidence that sex and gender play a meaningful role in how Parkinson’s is experienced, diagnosed, and treated, this is not consistently reflected in clinical studies or in our understanding of the condition. This International Women’s Day, we invite both researchers and the Parkinson’s…
Join our April Dog Walking Challenge 2026!
We are thrilled to announce that it’s time for your furry friends to model their bandanas once more – the April Dog Walking Challenge is back again for 2026! You and your furry friends are invited to join our challenge and walk 100km throughout the...
Kiltwalk 2026
Join the Kiltwalk challenge in support of Cure Parkinson’s. Team up with your family and friends and together, explore the streets of Glasgow, Edinburgh or Aberdeen while raising vital funds and awareness of Parkinson’s research. When you join #TeamCure you’ll receive: For more information, please...